Latest news
Loading news…
OSSIANIX
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Medium growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Philadelphia, Pennsylvania, United States Founded 2011 1-10 employees For Profit
OSSIANIX is a privately held biotherapeutics company that develops single domain antibodies based on the highly versatile VNAR structure
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
8
Patents
25
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 15
- Active products
- 10
- Patents granted
- 25
- Trademarks
- 0
- Top patent class
- Organic Chemistry
- IT spend
- $9M
Company Info
- Founded
- 2011
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 6
- HQ
- Philadelphia, Pennsylvania, United States
- Region
- Greater Philadelphia Area, Great Lakes, Northeastern US
- Diversity spotlight
- Women Founded
Signals & Scores
- Heat score
- High
- Growth score
- Medium
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- -0.1
8
professional contacts at OSSIANIX
Contact execs at OSSIANIX →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to OSSIANIX
Loading news…
FAQs about OSSIANIX
People who checked this page also checked these
Browse the full Acquirezy directory.